Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Mainz Biomed B.V. (MYNZ)
NASDAQ:MYNZ
Mainz Biomed B.V. (MYNZ) Stock Price & Analysis
36 Followers
MYNZ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.18 - $12.01
Previous Close$5.03
Volume35.75K
Average Volume (3M)46.29K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$17.14M
Total Debt (Recent Filing)$1.32M
Price to Earnings (P/E)-2.7
Beta0.40
Next Earnings
Sep 06, 2023EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding14,830,000
10 Day Avg. Volume38,217
30 Day Avg. Volume46,289
Standard Deviation0.22
R-Squared0.04
Alpha-0.00814
Financial Highlights & Ratios
Price to Book (P/B)5.27
Price to Sales (P/S)115.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$11.00Price Target Upside118.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Mainz Biomed B.V. News
Press ReleasesMainz Biomed Expands Commercial Footprint into Poland
Pre-EarningsMainz Biomed B.V. (MYNZ) Q1 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MYNZ FAQ
What was Mainz Biomed B.V.’s price range in the past 12 months?
Mainz Biomed B.V. lowest stock price was $3.18 and its highest was $12.01 in the past 12 months.
What is Mainz Biomed B.V.’s market cap?
Currently, no data Available
When is Mainz Biomed B.V.’s upcoming earnings report date?
Mainz Biomed B.V.’s upcoming earnings report date is Sep 06, 2023 which is in 90 days.
How were Mainz Biomed B.V.’s earnings last quarter?
Mainz Biomed B.V. released its earnings results on May 16, 2023. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.49 by $0.04.
Is Mainz Biomed B.V. overvalued?
According to Wall Street analysts Mainz Biomed B.V.’s price is currently Undervalued.
Does Mainz Biomed B.V. pay dividends?
Mainz Biomed B.V. does not currently pay dividends.
What is Mainz Biomed B.V.’s EPS estimate?
Mainz Biomed B.V.’s EPS estimate is -$0.42.
How many shares outstanding does Mainz Biomed B.V. have?
Mainz Biomed B.V. has 14,826,612 shares outstanding.
What happened to Mainz Biomed B.V.’s price movement after its last earnings report?
Mainz Biomed B.V. reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.49. Following the earnings report the stock price went down -2.186%.
Which hedge fund is a major shareholder of Mainz Biomed B.V.?
Currently, no hedge funds are holding shares in MYNZ
---
Mainz Biomed B.V. Stock Smart Score
Company Description
Mainz Biomed B.V.
Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.
---
---